| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,579 |
3,100 |
$290K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
1,634 |
1,358 |
$233K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,576 |
3,021 |
$183K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,081 |
792 |
$83K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,039 |
875 |
$78K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
937 |
767 |
$77K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
721 |
514 |
$50K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
1,324 |
1,238 |
$31K |
| 96127 |
|
1,292 |
1,099 |
$26K |
| 92551 |
|
1,283 |
1,074 |
$19K |
| 96160 |
|
1,245 |
914 |
$18K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
922 |
735 |
$15K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
334 |
297 |
$14K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
382 |
253 |
$13K |
| 90686 |
|
925 |
773 |
$11K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
26 |
26 |
$9K |
| D1206 |
Topical application of fluoride varnish |
306 |
234 |
$8K |
| 90698 |
|
427 |
310 |
$7K |
| 99173 |
|
842 |
728 |
$6K |
| 90674 |
|
338 |
287 |
$6K |
| 90651 |
|
338 |
262 |
$5K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
275 |
243 |
$4K |
| 90670 |
|
266 |
215 |
$4K |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
237 |
190 |
$3K |
| 83655 |
|
260 |
219 |
$3K |
| 90671 |
|
147 |
100 |
$3K |
| 90633 |
|
170 |
123 |
$3K |
| 99174 |
|
337 |
259 |
$3K |
| 90619 |
|
147 |
106 |
$2K |
| 90661 |
|
131 |
121 |
$2K |
| 90744 |
|
136 |
95 |
$2K |
| 85018 |
|
846 |
670 |
$2K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
18 |
12 |
$923.58 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
29 |
25 |
$907.70 |
| 83718 |
|
116 |
97 |
$894.52 |
| 90656 |
|
52 |
46 |
$868.92 |
| 90620 |
|
81 |
55 |
$862.26 |
| 90680 |
|
48 |
40 |
$793.78 |
| 91321 |
|
16 |
15 |
$593.20 |
| 90700 |
|
44 |
41 |
$552.64 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
44 |
41 |
$528.08 |
| 36416 |
|
124 |
93 |
$508.40 |
| 82465 |
|
115 |
97 |
$487.60 |
| 90734 |
|
50 |
33 |
$320.00 |
| 90710 |
|
20 |
12 |
$313.45 |
| 90696 |
|
20 |
12 |
$313.45 |
| 90713 |
|
23 |
20 |
$288.88 |
| 90715 |
|
18 |
14 |
$280.03 |
| 90647 |
|
20 |
19 |
$251.20 |
| 90716 |
|
14 |
12 |
$175.84 |
| 94760 |
|
14 |
13 |
$35.56 |